ホーム研究活動研究業績 > 放射線診療部

研究業績・放射線診療部[2011年度]

1)刊行論文

(1) 原著論文

  1. Ito K, Minamimoto R, Morooka M, Kubota K: A case of secondary hemochromatosis with high uptake of liver in F-18 FDG PET/CT imaging. Clin Nucl Med 36(7):606-8, 2011
  2. Ito K, Kurihara K, Ishibashi A, Morooka M, Mitsumoto T, Minamimoto R, Kubota K: Cut-off value for normal versus abnormal right-to-left shunt percentages using 99mTc-macroaggregated albumin. Nucl Med Commun 32(10):936-40, 2011
  3. Imabayashi E, Matsuda H, Yoshimaru K, Kuji I, Seto A, Shimano Y, Ito K, Kikuta D, Shimazu T, Araki N. Pilot data on telmisartan short-term effects on glucose metabolism in the olfactory tract in Alzheimer's disease. Brain Behav. 2011 Nov;1(2):63-9.
  4. Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, Kano T, Kaneko H, Takashima H, Mimoiri A. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol. 2011 Dec 29.
  5. Minamimoto R, Toyohara J, Seike A, Ito H, Endo H, Morooka M, Nakajima K, Mitsumoto T, Ito K, Okasaki M, Ishiwata K, Kubota K. 4'-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non-Small Cell Lung Cancer. J Nucl Med. 2012 Feb;53(2):199-206.
  6. Mitsumoto T, Kubota K, Sato T, Morooka M, Minamimoto R, Shimbo T, Muramatsu Y, Sasaki T, Ito K, Fukushi M. Validation for performing 11C-methionine and 18F-FDG-PET studies on the same day. Nucl Med Commun. 2012 Mar;33(3):297-304.
  7. Kubota K, Ito K, Morooka M, Minamimoto R, Miyata Y, Yamashita H, Takahashi Y, Mimori A. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. Ann N Y Acad Sci. 2011 Jun;1228:29-38.1749-6632.2011..
  8. Minamimoto R, Ito K, Kubota K, Morooka M, Masuda-Miyata Y, Hirai R, Kitahara H, Tanimura A, Hagiwara S, Miwa A. Clinical role of FDG PET/CT for methotrexate-related malignant lymphoma. Clin Nucl Med. 2011 Jul;36(7):533-7.
  9. Kubota K, Watanabe H, Murata Y, Yukihiro M, Ito K, Morooka M, Minamimoto R, Hori A, Shibuya H.Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study. Nucl Med Biol. 2011 Apr;38(3):347-51. Epub 2010 Oct 27.
  10. Minamimoto R, Morooka M, Kubota K, Ito K, Masuda-Miyata Y, Mitsumoto T, Hirai R, Okazaki O, Hiroe M. Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings. J Nucl Cardiol. 2011 May;18(3):516-20. No abstract available.
  11. Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, Kitajima K, Tateishi U, Morooka M, Ito K, Minamimoto R, Murakami K. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med. 2011 Jun;25(5):355-64. Epub 2011 Feb 23.
  12. Kimura Y, Sato N, Ito K, Kamiya K, Nakata Y, Saito Y, Matsuda H, Sugai K, Sasaki M, Sugimoto H. SISCOM technique with a variable Z score improves detectability of focal cortical dysplasia: a comparative study with MRI. Ann Nucl Med. 2012 Mar 17.
  13. Adachi Y, Sato N, Okamoto T, Sasaki M, Komaki H, Yamashita F, Kida J, Takahashi T, H Matsuda: Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. Neuroradiology 53(1):3-11, 2011
  14. Ota M, Nemoto K, Sato N, Mizukami K, Yamashita F, Asada T: Relationship between white matter T2 hyperintensity and cortical volume changes on magnetic resonance imaging in healthy elders. Int J Geriatr Psychiatry 26(9):886-92, 2011
  15. Ota M, Obu S, Sato N, Asada T: Neuroimaging study in subjects at high risk of psychosis revealed by the Rorschach test and first-episode schizophrenia. Acta Neuropsychiatrica 23(3):125-31, 2011
  16. Ota M, Ishikawa M, Sato N, Hori H, Sasayama D, Hattori K, Teraishi T, Nakata Y, Kunugi H. Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation. Acta Psychiatr Scand. 2012 Mar 20. doi: 10.1111/j.1600-0447.2012.01853.x.
  17. Ota M, Fujii T, Nemoto K, Tatsumi M, Moriguchi Y, Hashimoto R, Sato N, Iwata N, Kunugi H. A polymorphism of the ABCA1 gene confers susceptibility to schizophrenia and related brain changes. Prog Neuropsychopharmacol Biol Psychiatry 35(8):1877-83,2011
  18. Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N, Asada T: Automatic Voxel-Based Morphometry of Structural MRI by SPM8 plus Diffeomorphic Anatomic Registration Through Exponentiated Lie Algebra Improves the Diagnosis of Probable Alzheimer Disease. Am J Neuroradiol 33(6):1109-14, 2012
  19. 伊藤公輝, 中田安浩, 松田博史, 佐藤典子: 国立精神神経医療研究センターサイクロトロン解体報告. 核医学 2:156-160, 2011
  20. 伊藤公輝, 中田安浩, 松田博史, 佐藤典子: 国立精神・神経医療研究センター 医療用小型サイクロトロン解体作業報告 核医学 48(2):109-19, 2011

(2) 総説

  1. 神谷昂平, 佐藤典子: 検査からみる神経疾患 Hypertrophic olivary degeneration. Clin Neurosci 29(11):1312-3, 2011
  2. 有馬邦正,村田美穂, 佐藤典子: 先端認知症研究・医療施設の現在 国立精神・神経医療研究センター病院. Cognition and Dementia 10(2):78-81, 2011
  3. 岡崎哲也,登坂雅彦,佐藤典子: トルコ鞍、傍鞍部. 臨床放射線 56:581-590, 2011

(3) 著書

  1. 伊藤公輝: PET検査による腫瘍と血栓の鑑別. 心臓腫瘍学 南山堂, 東京, 398-401, 2011
  2. 伊藤公輝: PET製剤用サイクロトロン解体の体験記. PET journal 14:7-9, 2011
  3. 中田安浩: てんかんテキストNew Version 第3章 検査 E. MRI 宇川義一編 中山書店  2012
  4. 木村有喜男,石田悠,佐藤典子: 決定版 頭部画像診断パーフェクト 第11章 てんかんおよび痙攣に関連した脳症 土屋一洋編 羊土社 東京 2011

[ 前へ戻る ][ TOPへ戻る ]